Dr. Kaplan discusses patient selection for BPH treatments

“This is the beginning of an exploration and an identification,” says Steven A. Kaplan, MD.

In this video, Steven A. Kaplan, MD, discusses his patient selection process for BPH treatments and shares the take-home message of the study, “UroLift PUL compared to Rezum, TURP and GreenLight PVP: US Medicare and commercial claims analysis reveals lowest complications for PUL and highest retreatment for Rezum,” presented at the 2021 American Urological Association annual meeting. Kaplan is a professor of urology at the Icahn School of Medicine and director of the Men’s Wellness Program at Mount Sinai, New York, New York.